Influence investigation by the pharmacist follow after the medication

Influence investigation by the pharmacist follow after the medication - Influence investigation by the pharmacist follow after the medication

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000042922

Enrollment

385

Registered

2021-01-06

Start date

2021-01-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Follow with the telephone of the pharmacist Follow with the letter of the pharmacist No follow of the pharmacist

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patient whom antidiabetic agent was prescribed for more than 28 days

Exclusion criteria

Exclusion criteria: The patient who receives visit drug management instruction The patient who cannot list the VAS method by a physical reason The patient who does not have legal representative

Design outcomes

Primary

Measure	Time frame
medication adherence	—

Secondary

Measure	Time frame
The number of side effects Change of the HbA1c level Patient evaluation of the pharmacist follow	—

Countries

Japan

Contacts

Public ContactShutaro Yokota

Chiba Pharmaceutical Association Drug Information Center

drug-info@c-yaku.or.jp043-247-1352

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026